ALPS Advisors’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.29M | Sell |
42,929
-15,376
| -26% | -$820K | 0.01% | 349 |
|
|
2025
Q1 | $2.36M | Buy |
58,305
+1,865
| +3% | +$75.5K | 0.01% | 327 |
|
|
2024
Q4 | $1.57M | Buy |
56,440
+3,405
| +6% | +$94.7K | 0.01% | 380 |
|
|
2024
Q3 | $1.52M | Sell |
53,035
-904
| -2% | -$25.9K | 0.01% | 400 |
|
|
2024
Q2 | $1.27M | Buy |
53,939
+14,230
| +36% | +$334K | 0.01% | 416 |
|
|
2024
Q1 | $1M | Buy |
39,709
+2,477
| +7% | +$62.6K | 0.01% | 485 |
|
|
2023
Q4 | $869K | Sell |
37,232
-3,776
| -9% | -$88.2K | 0.01% | 514 |
|
|
2023
Q3 | $2.07M | Buy |
41,008
+343
| +0.8% | +$17.3K | 0.02% | 316 |
|
|
2023
Q2 | $1.9M | Buy |
40,665
+9,851
| +32% | +$460K | 0.02% | 318 |
|
|
2023
Q1 | $1.18M | Sell |
30,814
-911
| -3% | -$34.9K | 0.01% | 419 |
|
|
2022
Q4 | $1.74M | Buy |
31,725
+11,177
| +54% | +$613K | 0.02% | 327 |
|
|
2022
Q3 | $700K | Sell |
20,548
-229
| -1% | -$7.8K | 0.01% | 540 |
|
|
2022
Q2 | $196K | Sell |
20,777
-15,207
| -42% | -$143K | ﹤0.01% | 996 |
|
|
2022
Q1 | $511K | Sell |
35,984
-4,389
| -11% | -$62.3K | 0.01% | 428 |
|
|
2021
Q4 | $854K | Sell |
40,373
-2,356
| -6% | -$49.8K | 0.01% | 382 |
|
|
2021
Q3 | $955K | Sell |
42,729
-3,143
| -7% | -$70.2K | 0.01% | 397 |
|
|
2021
Q2 | $1.14M | Sell |
45,872
-16,942
| -27% | -$420K | 0.01% | 389 |
|
|
2021
Q1 | $1.82M | Buy |
62,814
+92
| +0.1% | +$2.67K | 0.02% | 326 |
|
|
2020
Q4 | $1.62M | Buy |
62,722
+18,473
| +42% | +$477K | 0.02% | 338 |
|
|
2020
Q3 | $1.36M | Buy |
44,249
+5,136
| +13% | +$158K | 0.02% | 288 |
|
|
2020
Q2 | $975K | Sell |
39,113
-12,805
| -25% | -$319K | 0.01% | 317 |
|
|
2020
Q1 | $1.1M | Sell |
51,918
-6,057
| -10% | -$128K | 0.02% | 264 |
|
|
2019
Q4 | $1.29M | Buy |
+57,975
| New | +$1.29M | 0.01% | 279 |
|